期刊文献+

亚胺培南/西司他丁输注时间对重症肺炎的疗效影响 被引量:11

Effect of different infusion time of imipenem/cilastatin on severe pneumonia
下载PDF
导出
摘要 目的观察亚胺培南/西司他丁不同输注时间对重症肺炎疗效的影响。方法117例重度肺炎患者分为三组:对照组38例、实验1组40例、实验2组39例。分别选择予亚胺培南/西司他丁常规0.5h静滴、静脉泵2h输注、静脉泵4h输注.疗程5~14d.比较三组实验室数据变化值及临床疗效。结果实验1组、实验2组与对照组临床疗效有效率比较,差异均具统计学意义(X^2分别=5.67、4.18,P均〈0.05)。而两实验组疗效比较,差异无统计学意义(X^2=O.12,P〉0.05)。三组细菌清除率比较,差异无统计学意义(X^2=0.34,P〉0.05)。三组患者的体温、白细胞计数(WBC)、C反应蛋白(CRP)指标改善情况比较,差异均有统计学意义(F分别=4.04、4.36、8.08,P均〈0.05),而临床肺部感染评分(CPIS)、APACHEⅡ评分改善程度、谷丙转氨酶(Alt)、肌酐(Cr)水平比较,差异无统计学意义(F分别=1.15、0.74、O.70、3.05,P均〉0.05)。进一步两两比较发现,实验1组、实验2组患者体温、WBC、CRP改善程度均较对照组明显(q分别=2.27、2.63:2.13、2.85:3.25、3.69,P均〈0.05)。而实验1组、实验2组的体温、WBC、CRP改善程度比较,差异无统计学意义(q分别=0.39、0.73、0.47,P均〉0.05)。结论亚胺培南/西司他丁输注时间延长后能明显改善重症肺炎患者的治疗效果.但输注时间延长至4h与2h比较,临床疗效无明显改善。 Objective To observe the effect of different infusion time of imipenem/cilastatin on severe pneumonia. Methods A total of 117 patients with severe pneumonia were divided into three groups..38 cases of the control group,40 cases of the experimental group 1,39 eases of the experimental group 2, The imipenem/cilastatin were given respectively conventional intravenous infusion for half an hour, intravenous infusion for 2 hours and intravenous infusion for 4 hours. The courses was 5 - 14 d. The laboratory data and clinical efficacy changes of the three groups were compared. Results Compared with the control group, the differences of clinical efficacy of two experimental groups were statistically significant (X^2=5.67, 4.18, P〈0.05), and the difference between two experimental groups was not statistically significant (X^2=0.12, P〉0.05).The difference of bacterial clearance rate among three groups was not statistically significant (x^2=O.34,P〉O.05). The changes of patient's temperature,white blood cell count (WBC), C-reactive protein (CRP) among three groups were statistically different(F=4.04, 4.36, 8.08,P〈0.05) while the changes of CPIS, APACHE I[ and the level of Alt, Cr among three groups was not statistically different (F=I.15, 0.74, 0.70, 3.05,P〉0.05). Compared with the control group,the changes of temperature, WBC, CRP of two experimental groups were more sharply(q=2.27,2.63;2.13,2.85;3.25,3.69,P〈 0.05) while there was no significant differences between experimental groups (q=0.39,0.73,0.47,P〉0.05). Conclusion Extension of imipenem/cilastatin infusion time can significantly improve the clinical effect of patients with severe pneumonia. The clinical effect had no improvement when the infusion time extend 2 hours to 4 hours.
出处 《全科医学临床与教育》 2015年第2期153-155,共3页 Clinical Education of General Practice
关键词 亚胺培南/西司他丁 重症肺炎 输注时间 imipenem/cilastatin severe pneumonia infusion time
  • 相关文献

参考文献7

  • 1贺鹤群,朱建华,叶继辉.重症肺炎的临床特征和死亡危险因素分析[J].实用医学杂志,2010,26(19):3532-3534. 被引量:54
  • 2Mizunaga S, Kamiyama T, Fukuda Y, et al. Influence of iuoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluo- roquinolones and carbapenems[J]. J Antimicrob Chemother, 2005, 56(1): 91-96.
  • 3Mandell LA,Wunderink RG,Anzueto A,et al.Infectious dis- eases society of America/American thoracic society consen- sus guidelines on the management of community-acquired pneumonia in adults [J]. Clin Infect Dis, 2007, 44 (suppl 2 ) : 27-72.
  • 4Gomez DS, Sanches-Giraud C, Silva CV, et al. Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment[J]. J Antibiot, 2014, 9( 11 ) : 599-607.
  • 5Jaruratanasirikul S, Sudsai T. Comparison of the pharmaco- dynamics of imipenem in patients with ventilator -associated pneumonia following administration by 2 or 0.5h infusion[J]. J Antimicrob Chemother, 2009, 63(3): 560-563.
  • 6Bedeni B, Vranes J, Sviben M, et al. Postantibiotic and post-beta-lactamase inhibitor effect of carbapenems against Pseudomonas aeruginosa strains producing VIM-met-allo beta-lactamases[J]. Chemotherapy, 2008, 54(3 ) : 118-193.
  • 7侯立朝,熊利泽,尚磊,李淑霞,陈绍洋,王雅丽,胡文能,霍婷婷,王一楠,刘菲,朱菲,李娜,申洁,李慧.亚胺培南/西司他丁对严重感染患者肾脏功能的影响[J].中华医院感染学杂志,2007,17(9):1135-1137. 被引量:2

二级参考文献23

共引文献54

同被引文献79

  • 1中华人民共和国卫生部,国家中医药管理局,解放军总后勤部卫生部.关于施行《抗菌药物临床应用指导原则》的通知[J].中华医学杂志,2004,84(22):1857-1857. 被引量:109
  • 2颜鲁青.美罗培南和亚胺培南治疗急性白细胞减少期并发肺部感染的成本-效果分析[J].中国药房,2007,18(29):2247-2248. 被引量:10
  • 3李炜清.临床药师在外科ICU药学服务的实践和体会[J].中国医院用药评价与分析,2007,7(6):475-476. 被引量:3
  • 4ZHOU Q T, HE B, ZHANG C, et al. Pharmacokineics and pharmacodynacics of meropenem in elderly chinese with lower respiratory tract infections:population phar- macokinetics analysis using nonlinear mixed - effects modelling and clinical pharmaeodynamies study [ J ]. Drugs Aging,2011,28 ( 11 ) :903 - 912.
  • 5MCKINNON P S,PALADINO J A,SCHENTAG J J. E- valuation of area under the inhibitory curve(AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazi- dime in serious bacterial infections [ J ]. Int J Antimi- crob Agent,2008,31 (4) :345 - 351.
  • 6SAMTANI M N, FLAMM R, KANIGA K, et al. Pharma- eokinetic - pharmaeodynamic - model - guided doripen- em dosing in critically ill patients [ J ]. Antimierob A- gents Chemother,2010,54 (6) :2 360- 2 364.
  • 7LEE L S, KINZIG- SCHIPPER S M, NAFZIGER A N, et al. Comparison of 30 - min and 3 - h infusion regi- ments for imipenem,/eilastatin and for meropenem eval- uated Monte Carlo simulation [ J ]. Diagn Mierobiol In- feet Dis,2010,68(3) :251 -258.
  • 8JARURATANASIRIKUL S, SUDSAI T. Comparison of the pharmacodynamies of imipenem in patients with ventilator- associated pneumonia following administra- tion by 2 or 0.5 h infusion[J]. J Antimierob Chemoth- er,2009,63 ( 3 ) :260 - 263.
  • 9VIAENE E, CHANTEUX H, SERVAIS H, et al. Com- parative stability studies of antipseudomonal beta - lae- tams of potential administration through portable elasto- meric pumps and motor- operated syringes( intensivecare units) [ J ]. Antimicrob Agents Chemother, 2002, 46(8) :2 327 -2 332.
  • 10BERTHOIN K, LE DUFF C S, MARCHAND- BRY- NAERT J, et al. Stability of meropenem and doripenem solutions for administration by continuous infusion [ J ]. J Antimierob Chemother,2010,65(5) :1 073 -1 075.

引证文献11

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部